PROVETOP

Biotinylated Human EPHA2 Protein

Catalog No: EPHA2-HB001

Species
Human
Expression System
HEK293
Tag
His, Avi

Product overview

Recombinant Biotinylated Human EPHA2 Protein is expressed in HEK293 cells with a His tag and Avi tag at the C-terminus. It contains amino acid residues Ala24-Val537 (UniProt accession: P29317-1).

Product Details

Molecular Aliases
Ephrin type-A receptor 2; Epithelial cell kinase; ECK; MPK-5; MPK5; SEK-2; SEK2; Myk2; AW54528
Protein Length
Ala24-Val537
Expression System
HEK293
Theoretical Molecular Weight
The protein has a predicted MW of 59.37 kDa. Due to glycosylation, the protein migrates to 60-70 kDa based on Bis-Tris PAGE result.
Purity
> 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC
Endotoxin
Less than 1 EU per μg by the LAL method.
Buffer / Formulation
Lyophilized from 0.22 μm filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization.
State
Lyophilized
Storage Conditions
-20 to -80°C for 12 months as supplied from date of receipt. -80°C for 3 months after reconstitution. Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles.
Reconstitution Advice
Dissolve the lyophilized protein in distilled water. Please refer to the Certificate of Analysis for detailed instructions.

Data Display

Bis-Tris PAGE
EPHA2-HB001 Bis-Tris-PAGE-white result

Biotinylated Human EPHA2 on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.

SEC-HPLC
EPHA2-HB001 SEC-HPLC result

The purity of Biotinylated Human EPHA2 is greater than 95% as determined by SEC-HPLC.

Background

Erythropoietin-producing hepatocellular receptor A2 (EphA2) receptor tyrosine kinase plays an important role in tissue organization and homeostasis in normal organs. EphA2 is overexpressed in a variety of types of solid tumours with oncogenic functions.

References

  1. Huang C, Chen Z, He Y, He Z, Ban Z, Zhu Y, Ding L, Yang C, Jeong JH, Yuan W, Yang L. EphA2 promotes tumorigenicity of cervical cancer by up-regulating CDK6. J Cell Mol Med. 2021 Mar;25(6):2967-2975. doi: 10.1111/jcmm.16337. Epub 2021 Feb 14. PMID: 33586348; PMCID: PMC7957165.

Have questions about this product?

Our technical team can help with product selection, application questions and order support.

Contact Technical Support